Canopy Growth to Enter German Medical Cannabis Market

Visit the Canopy Growth Corp Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.

The Globe and Mail is reporting big news for Canada’s leading licensed producer, Canopy Growth (TSXV: CGC) (OTC: TWMJF):

Canopy Growth said it would soon begin selling dried cannabis in pharmacies across Germany after securing an export licence from Health Canada on Wednesday.

The company has already announced deals in both Australia and Brazil recently, and this move positions it in front of legislative changes expected to take place in early 2017. The company plans to build a factory in Germany as well:

This is a very substantial market, and it’s probably the best place to enter the European Union from.

Bruce Linton CEO of Canopy GrowthBruce Linton, CEO of Canopy Growth

Canopy Growth is expected to move from the TSX Venture exchange to the Toronto Stock Exchange as early as next week.

Read Laurent Bastien’s and Mike Hager’s “Canada’s medical pot companies aim to grow export business”: http://www.theglobeandmail.com/news/toronto/canadas-medical-pot-companies-aim-to-grow-export-business/article31088427/

For fact-based information on Canopy Growth Corp, view the company’s sponsored Investor Dashboard.

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter